Alcohol increases breast cancer recurrence risks after early diagnosis

Article

Among women with a previous diagnosis of early state breast cancer, just 3 to 4 alcholic drinks per week could increase their risk for disease recurrence and death, especially if they are postmenopausal, overweight or obese.

Among women with a previous diagnosis of early-stage breast cancer, just 3 to 4 alcoholic drinks per week could increase their risks for disease recurrence and death, especially if they are postmenopausal, overweight, or obese.

Researchers administered a survey on alcohol use to 1,897 early-stage breast cancer survivors diagnosed during 1997 to 2000 who participated in the Life After Cancer Epidemiology study. The researchers then followed the participants for an average of about 7 years. Compared with no drinking, the authors of the study determined that consuming 6 g per day or more of alcohol was associated with an increased risk for breast cancer recurrence (HR, 1.35; 95% CI, 1.00-1.83) and death because of breast cancer (HR, 1.51; 95% CI, 1.00-2.29). Recurrence risk was higher for postmenopausal women (HR, 1.51; 95% CI, 1.05-2.19) and women who were overweight or obese (HR, 1.60; 95% CI, 1.08-2.38).

However, alcohol consumption was not associated with all-cause death and was possibly associated with a decreased risk for non-breast cancer death, alluding to its cardioprotective effects.

Recent Videos
HPV self-collection: Benefits, limitations, and future implications | Image Credit: forhers.com
Improving pediatric HPV vaccination rates: Early initiation and addressing disparities | Image Credit: blog.nemours.org.
New cervical cancer screening guidelines: What practitioners needs to know | Image Credit: forhers.com
COVID-19 Therapy Roundtable: Focusing on inpatient care
COVID-19 Therapy Roundtable: Defining the virus today and treatment options
How fezolinetant advances non-hormonal treatment of hot flashes | Image Credit: medschool.cuanschutz.edu
Contraceptive access challenges for college students in contraception deserts | Image Credit: linkedin.com.
Kameelah Phillips, MD, FACOG, NCMP, is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.